Live Breaking News & Updates on Malaysian consensus management guidelines

Stay informed with the latest breaking news from Malaysian consensus management guidelines on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Malaysian consensus management guidelines and stay connected to the pulse of your community

MOH starts Ivermectin trial for high risk Covid-19 patients

06 Jun 2021 / 07:14 H.
KUALA LUMPUR: The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals.
Health director-general Tan Sri Dr Noor Hisham Abdullah
(pix) said Ivermectin is a Food and Drug Administration (FDA) approved antiparasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases, however, the evidence is inconclusive to recommend routine use of Ivermectin for Covid-19 patients.
“The ‘off-label’ use of Ivermectin gained global attention due to some promising results by case studies and clinical trials.

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Raja-permaisuri-bainun , Noor-hisham-abdullah , Institute-for-clinical-research , Ministry-of-health , Drug-administration , National-pharmaceutical-regulatory-agency

Malaysia starts Ivermectin trial for high risk COVID-19 patients

Malaysia starts Ivermectin trial for high risk COVID-19 patients
outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.

Ipoh , Perak , Malaysia , Malaysian , Raja-permaisuri-bainun , Institute-for-clinical-research , Ministry-of-health-malaysia , World-health-organization , Ethics-committee , National-pharmaceutical-regulatory-agency , Clinical-research-centres , Randomised-evaluation

Dr Noor Hisham: Health Ministry has begun Ivermectin trial for high-risk Covid-19 patients

KUALA LUMPUR (Bernama): The Health Ministry and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 of the ministry's hospitals.

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Raja-permaisuri-bainun , Noor-hisham-abdullah , Institute-for-clinical-research , Drug-administration , National-pharmaceutical-regulatory-agency , Ethics-committee-on

Dr Noor Hisham: Health Ministry starts Ivermectin trial for high-risk Covid-19 patients | Malaysia

KUALA LUMPUR, June 5 — The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah said...

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Hari-anggara , Raja-permaisuri-bainun , Noor-hisham-abdullah , Instagram , Institute-for-clinical-research , Ministry-of-health